Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
2 other identifiers
interventional
N/A
1 country
16
Brief Summary
The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2003
Shorter than P25 for phase_2
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2003
CompletedFirst Posted
Study publicly available on registry
July 31, 2003
CompletedStudy Start
First participant enrolled
August 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2004
CompletedJanuary 26, 2011
January 1, 2011
6 months
July 28, 2003
January 25, 2011
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Newly diagnosed metastatic renal cell carcinoma
- Suitable for nephrectomy
You may not qualify if:
- Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma or within the last 3 years for any other cancer
- Significant cardiac event within 3 months of entry
- Any history of coronary angioplasty or history of myocardial infarction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (16)
Research Site
Los Angeles, California, United States
Research Site
Newark, Delaware, United States
Research Site
Tampa, Florida, United States
Research Site
Chicago, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Baltimore, Maryland, United States
Research Site
St Louis, Missouri, United States
Research Site
Lebanon, New Hampshire, United States
Research Site
Hackensack, New Jersey, United States
Research Site
Rochester, New York, United States
Research Site
The Bronx, New York, United States
Research Site
Cleveland, Ohio, United States
Research Site
Portland, Oregon, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Nashville, Tennessee, United States
Research Site
Salt Lake City, Utah, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 28, 2003
First Posted
July 31, 2003
Study Start
August 1, 2003
Primary Completion
February 1, 2004
Study Completion
February 1, 2004
Last Updated
January 26, 2011
Record last verified: 2011-01